|
|
Article: Lilly Announces Liver Safety Update/Straterra.
- Article from:
- PR Newswire UK Disclose
- Article date:
- December 17, 2004
CopyrightCOPYRIGHT 2004 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Date: December 17, 2004
For Release: Immediately
Refer to: Jennifer Bunselmeyer
(317) 997-1755 (cell)
(888) 462-2576 (pager)
Bunselmeyer_Jennifer@Lilly.com
Lilly Announces Important Liver Safety Update to Strattera(R) Label
Indianapolis, IN, December 17, 2004 - Eli Lilly and Company announced today
that it has added a bolded warning to the product label for Strattera, an
attention deficit/hyperactivity disorder (ADHD) medication. The bolded warning
indicates that the medication should be discontinued in patients with jaundice
(yellowing of the skin or whites of the eyes) or laboratory evidence of liver
injury. This label change discusses two reported ...